FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

79580006: Adrenal hormone (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
132027012 Adrenal hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
132027012 Adrenal hormone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
132027012 Adrenal hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

71 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adrenal hormone Is a Pituitary or adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Has disposition Adrenal hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Substance categorized by disposition false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a hormones et leurs métabolites et précurseurs false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Substance with molecular messenger mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing hydrocortisone and miconazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrocortisone and neomycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone- and nystatin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrocortisone and oxytetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrocortisone and potassium hydroxyquinoline sulfate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone- and urea-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing lidocaine and methylprednisolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone- and neomycin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing chlortetracycline and triamcinolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing neomycin and triamcinolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing nystatin and triamcinolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone+econazole (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clobetasol propionate 500 microgram/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone 5 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clobetasol propionate 0.05% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrocortisone in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Topical betamethasone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Topical beclomethasone (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Respiratory budesonide (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing budesonide in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Respiratory beclomethasone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclometasone-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing betamethasone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Parenteral betamethasone (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Respiratory fluticasone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing fluticasone in nasal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing fluticasone in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Rectal hydrocortisone preparations (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Topical compound hydrocortisone preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing methylprednisolone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Parenteral methylprednisolone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Oral triamcinolone (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Parenteral triamcinolone (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Topical triamcinolone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Corticosteroids used in the treatment of asthma The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrocortamate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Flunisolide 250mcg/inh inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Iodoquinol+hydrocortisone 1%/1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Flurandrenolide 4mcg tape The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely prednisone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Prednisone 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate 0.5mg/g cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Diflorasone diacetate 0.5mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate 0.5mg/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone probutate 1 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluocinolone acetonide 100 microgram/mL shampoo The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium succinate 40mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Desonide 500 microgram/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium succinate 125mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone 2% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely prednisone 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Diflorasone diacetate 0.05% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely prednisone 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium succinate 1g powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium succinate 500mg powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium succinate 2g powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Diflorasone diacetate 0.05% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone acetate 40mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely diflorasone diacetate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fludroxycortide 250 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fludroxycortide 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fludroxycortide 250 microgram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fludroxycortide 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 0.05% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 50mcg spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Flunisolide 250mcg/inh The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 40mg/mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone valerate) 1 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 250 microgram/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 5 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely triamcinolone 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Amcinonide 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone 100mg/60mL enema The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluorometholone 0.1% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone acetate 80mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Desonide 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 4mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone 100mg/60mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Halcinonide 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely halcinonide 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone acetate 40mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 50mcg/dose The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 4 of 6 Next End

This concept is not in any reference sets

Back to Start